Zhejiang Medicine Co Ltd
SSE:600216

Watchlist Manager
Zhejiang Medicine Co Ltd Logo
Zhejiang Medicine Co Ltd
SSE:600216
Watchlist
Price: 15.96 CNY -5.51% Market Closed
Market Cap: 15.3B CNY
Have any thoughts about
Zhejiang Medicine Co Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

73.9
Current
23.9
Median
16.6
Industry
Higher than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
73.9
=
Enterprise Value
14.2B CNY
/
EBIT
192.4m CNY
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
10.5
2-Years Forward
EV/EBIT
10.8
3-Years Forward
EV/EBIT
N/A

See Also

Discover More